Skip to main content

Table 1 Description of included individuals according to entry period

From: Change of treatment guidelines and evolution of ART initiation in rural South Africa: data of a large HIV care and treatment programme

  Period 1 Period 2 Period 3 P*
Group–n (%)
Men 6,643 (27.6) 2,640 (30.9) 2,582 (31.0) <0.001
Women < 40 years old 13,851 (57.5) 4,867 (57.0) 4,681 (56.2)  
Women40 years old 3,588 (14.9) 1,028 (12.1) 1,071 (12.8)  
CD4 count (cells/μL) - median [IQR]
In men 180 [71–341] 183 [74–335] 229 [100–386] <0.001
In women <40 years old 307 [164–481] 288 [158–458] 349 [213–520] <0.001
In women ≥40 years old 258 [135–432] 242 [119–419] 333 [161–522] <0.001
Age (years)-median [IQR]
In men 36.5 [30.4-44.5] 34.8 [28.7-43.0] 34.5 [28.3-42.0] <0.001
In women <40 years old 27.5 [23.4-32.6] 26.5 [22.5-31.2] 26.7 [22.4-31.6] <0.001
In women ≥40 years old 46.8 [43.2-51.9] 46.9 [42.9-53.0] 48.0 [43.7-53.4] <0.001
  1. IQR: Inter-Quartile Interval
  2. Period 1: January 1, 2007–March 31, 2010; Period 2: April 1, 2010–July 31, 2011; Period 3: August 1, 2011–September 15, 2012
  3. * p.value with Chi2 tests (for group) or Anova tests (for CD4 cells count and Age)
  4. HIV Hlabisa programme, KwaZulu-Natal, South Africa. 2007–2012